NCT03019952

Brief Summary

An analysis of data for adolescents and young adults diagnosed with Autism Spectrum Disorders (ASDs) who are evaluated as part of the Care Coordination, Assessment, and Responsive Engagement for transition-aged adolescents (t-CARE) program which replaced the former Autism Life Care Model (ALCM), which was a clinical program implemented between Fall 2014 and April 2016. The individuals enrolled in the program will be administered a standardized assessment battery during each visit with the care coordinator or study coordinator. The proposed study will analyze data gathered during each of the assessment periods in order to check the efficacy and viability of the protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 11, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 13, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2018

Completed
Last Updated

March 13, 2019

Status Verified

March 1, 2019

Enrollment Period

2.3 years

First QC Date

January 11, 2017

Last Update Submit

March 11, 2019

Conditions

Outcome Measures

Primary Outcomes (9)

  • Holmes and Rahe Stress Scale

    annually over 2 years

  • SRS-2

    annually over 2 years

  • Waisman Activities of Daily Living Scale

    annually over 2 years

  • Intolerance of Uncertainty

    annually over 2 years

  • PROMIS Multi-Domain 49

    monthly over 2 years

  • Temple University Community Participation (TUCP) measure

    quarterly over 2 years

  • PROMIS proxy measures

    quarterly over 2 years

  • PROMIS SF measures

    monthly over 2 years

  • Self-Determination Scale

    annually over 2 years

Secondary Outcomes (1)

  • Closure Survey

    after completion of 2 year study

Interventions

This is a longitudinal study. Adolescents or young adults with autism will participate in this study. Participants will be required to complete a baseline of assessment measures at enrollment and then monthly assessments (described in the study procedures below) during the first (approximately) 10-15 minutes of each visit with the t-CARE coordinator. The remainder of the visit will focus on care coordination and clinical treatment goals.

Eligibility Criteria

Age14 Years - 19 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Between 14 and 19 years of age upon entry into t-CARE
  • A primary diagnosis of Asperger's Syndrome or autism, as indicated by the Social Responsiveness Scale, Second Edition (SRS-2; Constantino \& Gruber, 2012)
  • English as primary language spoken
  • Ability to self-report (i.e. understand and answer assessment questions written at a third grade comprehension level) (self-report questions to be asked by study coordinator)

You may not qualify if:

  • A significant language delay
  • Significant psychosis as indicated through a semi-structured interview (Mini-International Neuropsychiatric Interview)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Penn State College of Medicine

Hershey, Pennsylvania, 17033, United States

Location

MeSH Terms

Conditions

Autism Spectrum Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Michael J. Murray, M.D.

    Hershey Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Psychiatry

Study Record Dates

First Submitted

January 11, 2017

First Posted

January 13, 2017

Study Start

January 1, 2016

Primary Completion

April 9, 2018

Study Completion

April 9, 2018

Last Updated

March 13, 2019

Record last verified: 2019-03

Locations